Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
Details for Australian Patent Application No. 2002341693 (hide)
International Classifications
Event Publications
27 February 2003 Complete Application Filed
Priority application(s): 60/324,165 21.09.01 US
26 June 2003 Application Open to Public Inspection
Published as AU-B-2002341693
29 May 2008 Application Accepted
Published as AU-B-2002341693
25 September 2008 Standard Patent Sealed
6 October 2011 Extension of Term of Standard Patents
Bristol-Myers Squibb Company The earliest first regulatory approval date provided by the patentee 21 Jul 2011 For the goods ELIQUIS apixaban
27 October 2011 Extension of Term of Standard Patents
Bristol-Myers Squibb Company The earliest first regulatory approval date provided by the patentee 21 Jul 2011 For the goods ELIQUIS apixaban Address for service in Australia: Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000
22 March 2012 Extension granted
Bristol-Myers Squibb Company The earliest first regulatory approval date provided by the patentee 21 Jul 2011 For the goods ELIQUIS apixaban Extension of Term of patent pursuant to Section 77 expires on 21 Jul 2026
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002341694-PROCESS FOR CLEANING COMPONENTS USING CLEANING MEDIA
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser